Patent litigation attorney

Allison Penfield

2 tracked appearances — 0 plaintiff · 2 defendant.

Specialty & background

Let me dig deeper into the tracked cases and any PTAB/appellate work.

Let me verify a few more details on notable cases and outcomes.

Allison C. Penfield — Attorney Summary

Specialty / focus areas. Penfield is a patent litigator whose tracked work centers on computer-implemented and image-processing technologies. Her two tracked appearances arise from the same dispute over aerial roof-estimation and 3D building-reconstruction patents (aerial imagery/photogrammetry). Public docket records also place her on life-sciences and medical-device matters — most prominently representing Acuitas Therapeutics in its declaratory-judgment/lipid-nanoparticle dispute relating to the Comirnaty mRNA vaccine technology, and appearing in matters involving blood-culture technology (Magnolia Medical Technologies v. Kurin) and cardiovascular devices (Abbott Cardiovascular Systems v. Edwards Lifesciences). Third-party analytics (Ex Parte) associate her docket with biotech, communications, and semiconductor/optics subject matter. She holds a B.A. in Physics, consistent with the technical cast of her patent work.

Side preference. In the tracked case list she appears exclusively on the defense side (0 plaintiff, 2 defendant), representing Nearmap US, Inc. against Eagle View Technologies. Her broader public record is not strictly one-sided, however: she is not a dedicated NPE/PAE plaintiffs' lawyer. At her prior firm she appeared for Acuitas Therapeutics as a plaintiff/product supplier seeking declaratory relief, and her practice is best characterized as representing technology operating companies in high-stakes patent disputes, predominantly on the defense side, with the occasional plaintiff-side/declaratory-judgment role.

Firm context, notable matters, and PTAB/appellate experience. Penfield is counsel at Groombridge, Wu, Baughman & Stone LLP (New York), a patent-litigation boutique founded in November 2022; the firm announced her promotion to counsel effective January 1, 2025. Before that she was a litigator at Paul, Weiss, Rifkind, Wharton & Garrison LLP, where her docket entries in the Acuitas matter originate. Her most prominent tracked matter is the Eagle View Technologies, Inc. v. Nearmap US, Inc. dispute (D. Utah, No. 2:21-cv-00283), an eight-patent aerial-imagery campaign in which Groombridge Wu (alongside Fish & Richardson) represented Nearmap; the district court stayed the case in August 2025 pending PTO and Federal Circuit proceedings, and the parties announced a global settlement in May 2026. Parallel IPRs (e.g., IPR2022-00734) resulted in PTAB findings of unpatentability, which the Federal Circuit affirmed in Eagle View Technologies, Inc. v. Nearmap US, Inc., No. 24-1488 (Fed. Cir. Feb. 3, 2026). The firm publicly describes her as having handled jury trials in federal district court, USPTO administrative proceedings, and appellate proceedings, and its LMG Life Sciences "Inter Partes Review Firm of the Year" recognition reflects an active PTAB practice. Note that the tracked case records do not themselves list separate IPR docket appearances for her personally, so her individual PTAB appearance history should be confirmed against PTAB records before being relied on.

Bar / education. Admitted in New York (2017); B.A. in Physics, Franklin & Marshall College (magna cum laude) and J.D., Boston University School of Law (magna cum laude, Boston University Law Review).

Caveat on sourcing: Biographical and practice details are drawn from the firm's own website and news releases (self-reported) and from public federal dockets; the technology-category breakdown attributed to Ex Parte is third-party analytic data and should be treated as indicative rather than authoritative.

Firms

Roles

  • of counsel2

Cases (2)